T1209 Twice-Daily Balsalazide Tablets Improve Patient Quality of Life After 2, 6, or 8 Weeks of Treatment: Results of Two Phase 3, Randomized, Double-Blind Multicenter Studies

✍ Scribed by Rosen, Alana A.; Sedghi, Shahriar; Shepard, Roland D.; Mareya, Shadreck M.; Huang, Shirley; Shaw, Audrey L.; Forbes, William P.

• Book ID: 122421333
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 103 KB
• Volume: 136
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(09)62404-5